Erlotinib
Products in Health Canada’s databases that list Erlotinib as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
Also listed as “Erlotinib (Erlotinib Hydrochloride)” (14). How names are joined
- Drug products
- 14
- 11 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 1
- Products in all
- 14
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| APO-ERLOTINIB (25 MG) | 02461862 | Marketed | Apotex Inc. | |
| APO-ERLOTINIB (100 MG) | 02461870 | Marketed | Apotex Inc. | |
| APO-ERLOTINIB (150 MG) | 02461889 | Marketed | Apotex Inc. | |
| PMS-ERLOTINIB (150 MG) | 02454394 | Marketed | Pharmascience Inc. | |
| TEVA-ERLOTINIB (25 MG) | 02377691 | Marketed | Teva Canada Limited | |
| TEVA-ERLOTINIB (100 MG) | 02377705 | Marketed | Teva Canada Limited | |
| TEVA-ERLOTINIB (150 MG) | 02377713 | Marketed | Teva Canada Limited | |
| NAT-ERLOTINIB (25 MG) | 02483912 | Dormant | Natco Pharma (Canada) Inc | |
| NAT-ERLOTINIB (100 MG) | 02483920 | Dormant | Natco Pharma (Canada) Inc | |
| NAT-ERLOTINIB (150 MG) | 02483939 | Dormant | Natco Pharma (Canada) Inc | |
| PMS-ERLOTINIB (100 MG) | 02454386 | Dormant | Pharmascience Inc. | |
| TARCEVA (25 MG) | 02269007 | Cancelled Post Market | Hoffmann-La Roche Limited | |
| TARCEVA (100 MG) | 02269015 | Cancelled Post Market | Hoffmann-La Roche Limited | |
| TARCEVA (150 MG) | 02269023 | Cancelled Post Market | Hoffmann-La Roche Limited |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- TARCEVAJuly 7, 2005 · NOC 7211